The Benefits From Giving Makers Of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data

标题
The Benefits From Giving Makers Of Conventional ‘Small Molecule’ Drugs Longer Exclusivity Over Clinical Trial Data
作者
关键词
-
出版物
HEALTH AFFAIRS
Volume 30, Issue 1, Pages 84-90
出版商
Health Affairs (Project Hope)
发表日期
2011-01-06
DOI
10.1377/hlthaff.2009.1056

向作者/读者发起求助以获取更多资源

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started